We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Reducing long-term sick leave in employees with a common mental health condition as a main condition or alongside another condition
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
The purpose of the return to work pilot study is to provide employees on long-term sick leave with early and positive workplace communication that supports the employee’s wellbeing whilst on sick leave and when returning to work.
Many people go on long-term sick leave for lots of different reasons including back pain, poor mental health and conditions that might need treatment or recovery time. Sometimes, those on long-term sick leave might experience poor mental wellbeing even if that is not the reason for their sick leave. Research shows that poor mental wellbeing is linked to longer lengths of sickness absence. However, a number of studies show that employees who experience good quality communication and contact with their workplace can feel positive about their work, are more likely to feel ready to return to work and to also return to work earlier than they expected. They are also further likely to have a more positive work experience once they are back at work.
Our return to work pilot study, called PROWORK, provides employees who are on sick leave with an online toolkit they can access from a website. The online toolkit provides new guidance and step-by-step support from initial sick leave through to returning to work for the employee. The employee’s manager, workplace return-to-work contact or employer will be asked to use a similar online toolkit that provides them with step-by-step guidance in how to support the employee whilst on sick leave and when returning to work.
Our research wants to see how practical it is for employees on long term sick leave and the person responsible for managing their return to work to use the online toolkits and to follow the steps. We also want to see whether the toolkits are effective in reducing the number of days an employee is on long-term sick leave.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35986424/ (added 22/08/2022)2023 Other publications in https://pubmed.ncbi.nlm.nih.gov/37660008/ Toolkit development (added 25/04/2025)
You can take part if:
You may not be able to take part if:
Employee: 1. Under 18 years of age2. On sick leave with a psychotic episode such as schizophrenia, or with substance abuse 3. On sick leave whilst under formal investigation for misconduct or in the formal process of disciplinary action4. On sick leave being diagnosed with cancer and signed off work for at least 6 months5. On sick leave due to a neurological condition (e.g. multiple sclerosis, Parkinson's disease, dementia)
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
This information has not yet been provided by the study team. You'll have an opportunity to discuss any risks and benefits that may be associated with this study prior to consenting to taking part.
Dr
Fehmidah
Munir
+44 (0)1509 228228
f.munir@lboro.ac.uk
The study is sponsored by Loughborough University and funded by Midlands Engine.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
You can print or share the study information with your GP/healthcare provider or contact the research team directly.